These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 39061185)

  • 1. Anticancer Effect of Pt
    Elias MG; Fatima S; Mann TJ; Karan S; Mikhael M; de Souza P; Gordon CP; Scott KF; Aldrich-Wright JR
    Cancers (Basel); 2024 Jul; 16(14):. PubMed ID: 39061185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent Chlorambucil-Platinum(IV) Prodrugs.
    Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes.
    Ng NS; Wu MJ; Myers SJ; Aldrich-Wright JR
    J Inorg Biochem; 2018 Feb; 179():97-106. PubMed ID: 29197671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells.
    Elias MG; Aputen AD; Fatima S; Mann TJ; Karan S; Mikhael M; de Souza P; Gordon CP; Scott KF; Aldrich-Wright JR
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells.
    Khoury A; Sakoff JA; Gilbert J; Karan S; Gordon CP; Aldrich-Wright JR
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum(IV) Derivatives of [Pt(1
    Kostrhunova H; McGhie BS; Markova L; Novakova O; Kasparkova J; Aldrich-Wright JR; Brabec V
    J Med Chem; 2023 Jun; 66(12):7894-7908. PubMed ID: 37285472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1
    Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analyses of cytotoxicity and molecular mechanisms between platinum metallointercalators and cisplatin.
    Wang S; Wu MJ; Higgins VJ; Aldrich-Wright JR
    Metallomics; 2012 Aug; 4(9):950-9. PubMed ID: 22814756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator.
    Wang S; Higgins VJ; Aldrich-Wright JR; Wu MJ
    J Chem Biol; 2012 Apr; 5(2):51-61. PubMed ID: 23226166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced potency of a chloro-substituted polyaromatic platinum(II) complex and its platinum(IV) prodrug against lung cancer.
    Baz J; Khoury A; Elias MG; Mansour N; Mehanna S; Hammoud O; Gordon CP; Taleb RI; Aldrich-Wright JR; Daher CF
    Chem Biol Interact; 2024 Jan; 388():110834. PubMed ID: 38103879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity.
    Khoury A; Sakoff JA; Gilbert J; Scott KF; Karan S; Gordon CP; Aldrich-Wright JR
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
    Wu Y; Zhao D; Shang J; Huang W; Chen Z
    Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents.
    McGhie BS; Sakoff J; Gilbert J; Gordon CP; Aldrich-Wright JR
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
    Hajipour F; Mahdavinia M; Fereidoonnezhad M
    Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl
    Hoeschele JD; Kasparkova J; Kostrhunova H; Novakova O; Pracharova J; Pineau P; Brabec V
    J Biol Inorg Chem; 2020 Sep; 25(6):913-924. PubMed ID: 32851480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro cytotoxicity and in-vivo antitumor activity of two platinum complexes with 1,3-dimethyl pentyl glycine ligand against breast cancer.
    Bazsefidpar P; Eftekhar E; Jahromi MZ; Nikpoor AR; Moghadam ME; Zolghadri S
    J Inorg Biochem; 2023 Apr; 241():112144. PubMed ID: 36706492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review).
    Chaney S
    Int J Oncol; 1995 Jun; 6(6):1291-305. PubMed ID: 21556672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
    Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
    BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.